GSK Roundup: A Timeline Of Its China Corruption Scandal
This article was originally published in PharmAsia News
PharmAsiaNews, which has been reporting the GlaxoSmithKline China story through its reporters as well as the world's press, has amassed the following up-to-date timeline of developments.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.